Back
Marker Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
MRKR
Marker Therapeutics, Inc.
Last Price:
$1.39
Seasonality Move:
31.4%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRKR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Marker Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.35 | Buy |
| 20-day SMA: | 1.31 | Buy |
| 50-day SMA: | 1.12 | Buy |
| 200-day SMA: | 1.22 | Buy |
| 8-day EMA: | 1.34 | Buy |
| 20-day EMA: | 1.29 | Buy |
| 50-day EMA: | 1.18 | Buy |
| 200-day EMA: | 1.44 | Sell |
Marker Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 60.71 | Buy |
| Chaikin Money Flow: | 351614 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.09 - 1.41) | Buy |
| Bollinger Bands (100): | (0.91 - 1.25) | Buy |
Marker Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marker Therapeutics, Inc. Stock
Is Marker Therapeutics, Inc. Stock a Buy?
-
Marker Therapeutics, Inc. share price is 1.42 while MRKR 8-day simple moving average is 1.35, which is a Buy signal.
-
The stock price of MRKR is 1.42 while Marker Therapeutics, Inc. 20-day SMA is 1.31, which makes it a Buy.
-
Marker Therapeutics, Inc. 50-day simple moving average is 1.12 while MRKR share price is 1.42, making it a Buy technically.
-
MRKR stock price is 1.42 and Marker Therapeutics, Inc. 200-day simple moving average is 1.22, creating a Buy signal.
MRKR Technical Analysis vs Fundamental Analysis
Buy
57
Marker Therapeutics, Inc. (MRKR)
is a Buy
Is Marker Therapeutics, Inc. a Buy or a Sell?
-
Marker Therapeutics, Inc. stock is rated a BuyThe current Marker Therapeutics, Inc. [MRKR] share price is $1.42. The Score for MRKR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Marker Therapeutics, Inc. Stock Info
Market Cap:
23.7M
Price in USD:
1.42
Share Volume:
468.8K
Marker Therapeutics, Inc. 52-Week Range
52-Week High:
4.07
52-Week Low:
0.81
Buy
57
Marker Therapeutics, Inc. (MRKR)
is a Buy
Marker Therapeutics, Inc. Share Price Forecast
-
What is the Marker Therapeutics, Inc. stock price today?The Marker Therapeutics, Inc. stock price is 1.42 USD today.
-
Will MRKR stock go up or go down?Marker Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Marker Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marker Therapeutics, Inc. is not overvalued.
Is Marker Therapeutics, Inc. Stock a Buy?
-
Marker Therapeutics, Inc. share price is 1.42 while MRKR 8-day exponential moving average is 1.34, which is a Buy signal.
-
The stock price of MRKR is 1.42 while Marker Therapeutics, Inc. 20-day EMA is 1.29, which makes it a Buy.
-
Marker Therapeutics, Inc. 50-day exponential moving average is 1.18 while MRKR share price is 1.42, making it a Buy technically.
-
MRKR stock price is 1.42 and Marker Therapeutics, Inc. 200-day simple moving average is 1.44, creating a Sell signal.
Fundamental Analysis of Marker Therapeutics, Inc.
Is Marker Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.15 per share.
Technical Analysis of Marker Therapeutics, Inc.
Should I short Marker Therapeutics, Inc. stock?
-
MRKR Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting Marker Therapeutics, Inc. is a Buy
-
Marker Therapeutics, Inc. Relative Strength Index (RSI) is 60.71, which suggest Marker Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Marker Therapeutics, Inc. is (1.09 - 1.41), which suggest Marker Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Marker Therapeutics, Inc. is (0.91 - 1.25), which suggest Marker Therapeutics, Inc. is a Buy
* Marker Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.